Research-based content. This article is based on published research and publicly available pricing data. It is not medical advice. Do not start, stop, or change any medication without consulting a licensed healthcare professional. See sources below.
Ashwagandha in India — Uses, Benefits, Dosage, Side Effects & Brand Comparison (2026)
Approximate Price Comparison (per month supply)
India
₹123 – ₹1,399
US
$15 – $40
UK
£10 – £30
Prices are approximate and vary by dosage, brand, and pharmacy. Based on publicly available data.
Indian Manufacturers
Ashwagandha is India’s most popular herbal supplement. It’s also one of the most misunderstood.
Walk into any pharmacy in Delhi, Bengaluru, or Mumbai and you’ll find at least 5 brands claiming to sell “pure ashwagandha.” What they won’t tell you: the ₹123 bottle and the ₹1,399 bottle contain wildly different amounts of active compounds — sometimes with a 70-fold difference. One in five commercial products tested in lab studies contained banned leaf material. And 35 people have developed liver injury from this “safe, natural” supplement since 2017.
This is not an anti-ashwagandha article. Clinical trials show real, measurable benefits — a 23% cortisol reduction, significant muscle strength gains, improved sperm motility by 87%. But the gap between what clinical science proves and what Instagram reels claim is vast.
Here’s what the research actually says — the doses that worked, the brands worth paying for, the side effects nobody warns about, and the 471 drug interactions your Ayurvedic practitioner probably hasn’t mentioned.
What Is Ashwagandha, Exactly?
Withania somnifera — commonly called ashwagandha, Indian ginseng, or winter cherry — is a small shrub native to India, the Middle East, and parts of Africa. The name translates to “smell of horse” in Sanskrit, referring both to the root’s distinct odour and the traditional belief that it imparts horse-like strength.
In Ayurveda, ashwagandha is classified as a Rasayana — a rejuvenating tonic believed to promote longevity. It has been used for over 3,000 years in Indian traditional medicine for conditions ranging from stress and fatigue to male infertility and joint pain.
The active compounds responsible for ashwagandha’s effects are called withanolides — a group of steroidal lactones. The two most studied are:
- Withaferin-A — found primarily in leaves, linked to anti-cancer properties in lab studies but also to liver toxicity in humans. This is the compound that triggered the FSSAI ban on ashwagandha leaves in April 2026.
- Withanolide-D — found primarily in roots, associated with neuroprotective and anti-inflammatory effects.
The distinction between root and leaf matters enormously — and most Indian consumers don’t know which part their supplement contains.
Clinically Proven Benefits: What the Data Actually Shows
Forget the “100 benefits of ashwagandha” listicles. Here are the outcomes that have been demonstrated in randomized, placebo-controlled clinical trials with specific doses and measurable results.
1. Cortisol Reduction (Strongest Evidence)
Ashwagandha’s most consistent clinical finding is cortisol reduction. Multiple independent studies confirm this:
| Study | Extract/Dose | Duration | Cortisol Reduction | Statistical Significance |
|---|---|---|---|---|
| Lopresti 2019 | Shoden 240mg/day | 60 days | -23% (males -22%, females -25%) | P < .001 |
| Choudhary 2017 | KSM-66 300mg/day | 60 days | -19.15% | Significant |
| Choudhary 2017 | KSM-66 150mg/day | 60 days | -11.44% | Significant |
| Weight study | KSM-66 600mg/day | 8 weeks | -22.2% (17.25 to 13.41 µg/dL) | P = .0019 |
A meta-analysis of 9 RCTs covering 558 patients confirmed a mean cortisol reduction of 2.58 µg/dL.
The contradiction nobody talks about: A separate systematic review found that ashwagandha significantly reduced cortisol but not perceived stress. Your blood cortisol drops, but you might not feel less stressed. The biochemical marker improves; the subjective experience may not follow.
This matters if you’re taking ashwagandha for stress relief based on how you feel rather than lab numbers.
2. Muscle Strength and Body Composition
For men doing resistance training, KSM-66 showed meaningful results:
- Bench press strength: +46.0 kg vs +26.4 kg in placebo group (8 weeks)
- Leg extension: +14.5 kg vs +9.8 kg in placebo group
- Body fat reduction: Significantly greater than placebo
- Testosterone increase: +96.2 ng/dL vs +18.0 ng/dL in placebo
Reality check: These gains are estimated at 25–40% of what creatine provides for muscle and 40–60% for strength. Ashwagandha is a supplement, not a steroid. If your training and nutrition are poor, no amount of ashwagandha will compensate.
For those interested in exercise routines that complement supplementation, our guide on best exercises to lose belly fat at home and gym in India covers evidence-based workout protocols.
3. Weight Management
An 8-week RCT using KSM-66 at 600mg/day in chronically stressed adults found:
- Body weight: -2.32 kg vs -1.13 kg in placebo (P = .0148)
- BMI: -0.79 kg/m² vs -0.38 in placebo (P = .0096)
- Uncontrolled eating score: -4.85 vs -2.58 (P = .0247)
- Emotional eating: -1.50 vs -0.38 (P = .0135)
- Happiness (OHQ): +19.18% increase (P < .0001)
The mechanism isn’t fat-burning — it’s cortisol-driven. Chronic stress elevates cortisol, which drives visceral fat accumulation and emotional eating. By reducing cortisol, ashwagandha addresses one upstream cause of stress-related weight gain.
If you’re exploring pharmaceutical approaches to weight management, compare these modest herbal results with semaglutide (Ozempic/Wegovy) data — where weight loss averages 15–17% of body weight.
4. Testosterone and Male Fertility
The testosterone data is real but overhyped:
| Population | Dose | Duration | Result |
|---|---|---|---|
| Resistance training males | KSM-66 600mg/day | 8 weeks | +96.2 ng/dL vs +18.0 placebo |
| Stressed overweight males | Shoden 240mg/day | 60 days | +11.4% (P = .038) |
| Infertile males | Root powder 5g/day | 3 months | Improved testosterone, LH, FSH |
For male fertility specifically, a 2026 RCT (n=76) using KSM-66 at 600mg/day showed:
- Ejaculate volume: +36%
- Total sperm count: +38%
- Sperm motility: +87%
- Erectile function, sexual desire, orgasmic function: All significantly improved (P < .001)
Important nuance: The testosterone effect was not significant in women (+0.2%, P = not significant in the Shoden study). Ashwagandha is not a unisex testosterone booster — the male-specific effect is likely mediated through cortisol reduction’s impact on the hypothalamic-pituitary-gonadal axis.
For couples exploring fertility options, our IVF treatment guide for India covers when supplements alone may not be sufficient.
5. Sleep Quality
A meta-analysis of 5 RCTs covering 400 participants found ashwagandha significantly improved sleep quality. Effects were more pronounced at doses above 600mg/day and durations longer than 8 weeks.
The irony: The active sleep-inducing compound in ashwagandha is triethylene glycol (TEG) — identified by University of Tsukuba researchers in 2017. TEG is found primarily in leaves, not roots. The withanolide-rich root extract was ineffective at inducing sleep in their mouse study; only the water extract containing TEG worked.
This creates a paradox: the FSSAI-banned part of the plant (leaves) contains the sleep-promoting compound. Root-only extracts like KSM-66 may have indirect sleep benefits through cortisol reduction, but the direct sleep mechanism is leaf-based.
6. Thyroid Function
An 8-week study in 50 subclinical hypothyroid patients using 600mg/day ashwagandha root extract showed:
- T3 increased by 41.5% (P significant)
- T4 increased by 19.6% (P significant)
- TSH normalized in several patients
This is not a subtle effect. A 41.5% T3 increase has real clinical implications — which is exactly why it’s dangerous in certain contexts (see Side Effects section below).
7. Aerobic Capacity
A meta-analysis of 4 RCTs (142 participants, 330–1,000mg/day, 2–12 weeks) found ashwagandha significantly improved VO₂max compared to placebo. Combined with the cortisol and body composition data, this makes ashwagandha one of the few herbal supplements with consistent exercise performance evidence.
Dosage: What Clinical Trials Actually Used
The single biggest mistake Indians make with ashwagandha is dose confusion. The label says “take 1–2 capsules daily.” Clinical trials used very specific doses of very specific extracts.
Clinically Validated Doses
| Goal | Extract | Daily Dose | Duration | Key Study |
|---|---|---|---|---|
| Cortisol reduction | Shoden (35% withanolides) | 240mg (= 84mg withanolides) | 60 days | Lopresti 2019 |
| Weight management | KSM-66 (>5% withanolides) | 600mg (300mg × 2) | 8 weeks | Choudhary 2017 |
| Muscle strength | KSM-66 | 600mg (300mg × 2) | 8 weeks | Wankhede 2015 |
| Sleep improvement | Various | >600mg/day | >8 weeks | Meta-analysis 2023 |
| Testosterone/fertility | KSM-66 | 600mg (300mg × 2) | 8–12 weeks | Multiple RCTs |
| Thyroid support | Root extract | 600mg/day | 8 weeks | Sharma 2018 |
| Minimum effective (stress) | KSM-66 | 250mg/day | 8 weeks | Dose-response study |
Dose-Response: More Is Better (To a Point)
A dedicated dose-response study (n=60, 8 weeks) tested 250mg vs 600mg of KSM-66:
- 250mg/day: Cortisol reduced (P < 0.05), perceived stress reduced (P < 0.05)
- 600mg/day: Cortisol reduced (P < 0.0001), perceived stress reduced (P < 0.001)
Clear dose-response relationship. The 600mg dose was significantly more effective.
Why Your Generic Churna Delivers Less Than You Think
Here’s the math most people don’t do:
- KSM-66 at 600mg with >5% withanolides = ~30mg active withanolides
- Shoden at 240mg with >35% withanolides = ~84mg active withanolides
- Generic ashwagandha churna at 1,000mg with 0.5–2% withanolides = 5–20mg active withanolides
You’d need 2–6 grams of generic powder to match what 600mg of KSM-66 delivers. And 3–16 grams to match Shoden. At those quantities, you’re also ingesting significantly more plant material with unknown contaminants.
Cycling: Should You Take Breaks?
Most clinical trials lasted only 8–12 weeks. No long-term RCT beyond that exists. Community protocols suggest:
- Standard cycle: 8–12 weeks on, 2–4 weeks off
- Alternative: 6–8 weeks on, 1–2 weeks off
- Micro-cycling: 5 days on (weekdays), 2 days off (weekends)
One 12-month observational study (n=191, KSM-66) found only 9.4% had mild adverse events, no significant liver enzyme changes, and sustained cortisol reduction and testosterone increases. But this was observational, not placebo-controlled — a weaker evidence standard.
Signs you need a break: Diminishing effects, needing higher doses for the same result, emotional blunting, or feeling “flat.”
How to stop safely: Taper by 25% per week over 2–4 weeks. Do not stop abruptly — withdrawal symptoms are clinically documented (see below).
Side Effects: What Nobody Warns You About
This is where the internet fails you. Most ashwagandha content lists “mild digestive discomfort” and moves on. The real risk profile is significantly more serious.
1. Liver Damage (35 Case Reports Since 2017)
This is not theoretical. An Indian case series documented 8 patients with ashwagandha-associated liver injury:
- 6 males, 2 females. Median age 49 (range 31–75)
- Dose range: 500mg/day to 10–15g/day
- Onset: As early as 14 days. Median 45 days. Up to 540 days.
- Lab values at presentation: Total bilirubin 13.8 mg/dL, AST 171 U/L, ALT 173 U/L, INR 1.85
- Patterns: Cholestatic (4 patients), hepatocellular (3), mixed (1)
- Symptoms: Jaundice (87.5%), pruritus (62.5%), lethargy
- Deaths: 3 out of 8 (37.5%) — all 3 had pre-existing chronic liver disease presenting as acute-on-chronic liver failure
- Survivors: Recovered in 1–4 months after discontinuation
Who is most at risk: Anyone with pre-existing liver disease — fatty liver, hepatitis B/C, alcoholic liver disease, cirrhosis. All 3 deaths occurred in patients with underlying chronic liver conditions.
The suspected hepatotoxic compound is withaferin-A, found in higher concentrations in leaves — one reason FSSAI banned ashwagandha leaves in April 2026.
If you’re taking ashwagandha and experience yellowing of skin/eyes, dark urine, persistent nausea, or upper right abdominal pain — stop immediately and get a liver function test. For severe cases, liver transplant may become necessary.
Compare this with paracetamol (Dolo 650) — another commonly consumed substance where liver toxicity is dose-dependent and often underestimated.
2. Emotional Blunting and Anhedonia
Zero clinical trials document this. Yet hundreds of users on Reddit, health forums, and social media report it.
Reported experiences include:
- Crossing from “relaxed” to “emotionally detached”
- Inability to feel pleasure from music, exercise, or physical intimacy
- Blunted temperature sensation
- Cognitive fog
- Reduced orgasm intensity
- One user reported anhedonia persisting 5+ months after stopping
- Another reported 2.5 years of persistent emotional numbness after discontinuation
The proposed mechanism: Chronic ashwagandha use may reduce sensitivity of 5-HT1A receptors and increase sensitivity of 5-HT2 receptors — a pathway that mirrors Post-SSRI Sexual Dysfunction (PSSD).
Why clinical trials miss this: Trials typically run 8–12 weeks and use structured questionnaires designed to measure anxiety and stress. These instruments don’t capture anhedonia, emotional flattening, or subtle changes in pleasure perception. You can score “less anxious” on a HAM-A scale while simultaneously feeling emotionally dead — and the study would record only the positive result.
3. Withdrawal Symptoms (Clinically Documented)
A published case report describes a 20-year-old male taking KSM-66 at 600mg/day who abruptly stopped:
- Day 2: Symptoms began — tachycardia (89 bpm), insomnia, anxiety, hypertension, loss of appetite
- Day 7: Presented to the emergency department
- Treatment: Hydroxyzine prescribed, psychiatric follow-up referred
- Mechanism: GABAergic pathway dependence, similar to benzodiazepine/alcohol withdrawal
Commonly reported withdrawal symptoms:
- Rebound anxiety and panic attacks
- Insomnia
- Brain fog and difficulty concentrating
- Headaches
- Depression and loss of motivation
- Nausea
Symptoms typically appear within 1–3 days and resolve within 2 weeks. But some users report prolonged effects lasting months.
The safe way to stop: Taper gradually — reduce your dose by 25% each week over 2–4 weeks. Never go cold turkey after daily use exceeding 4 weeks.
4. Thyroid Disruption
Ashwagandha’s thyroid effects are a double-edged sword:
- For subclinical hypothyroidism (without medication): Potentially beneficial — T3 increased 41.5%, T4 increased 19.6%
- For patients on levothyroxine (Thyronorm, Eltroxin): Dangerous — ashwagandha can push thyroid levels too high, risking thyrotoxicosis (racing heart, anxiety, tremors, weight loss, heat intolerance)
- For Hashimoto’s thyroiditis: Paradoxically harmful — ashwagandha stimulates the immune system, which can flare the autoimmune attack on the thyroid
Case report: A 73-year-old woman developed supraventricular tachycardia and hyperthyroid symptoms after 2 years of self-treating with ashwagandha alongside her thyroid medication.
Bottom line: If you’re on any thyroid medication, do not start ashwagandha without getting your T3, T4, and TSH levels tested first. Retest after 4 weeks of supplementation.
5. Gastrointestinal Issues
The most common reported side effects in clinical trials:
- Mild giddiness (reported in weight management RCT)
- Hyperacidity
- Head heaviness
- Nausea (typically in the first week)
- Diarrhoea (more common with leaf-containing products)
In the weight management trial, 4% of participants (2 out of 52) reported adverse events. In the 12-month observational study, 9.4% experienced mild adverse events.
6. Parasomnia and Cognitive Effects
A case report published in Cureus documented a patient who developed parasomnia (abnormal sleep behaviours), acute confusion, and transient amnesia temporally associated with ashwagandha ingestion.
While isolated, this is worth noting — particularly because ashwagandha is widely marketed as a sleep aid.
Drug Interactions: 471 Known Interactions
Ashwagandha interacts with 471 drugs — 7 major, 279 moderate, 185 minor. This is one of the highest interaction counts of any herbal supplement.
Major (Avoid These Combinations)
| Drug Category | Examples | Risk |
|---|---|---|
| Sedatives/Benzodiazepines | Alprazolam, Diazepam, Lorazepam, Zolpidem | Synergistic sedation, respiratory depression, potential coma |
| Immunosuppressants | Cyclosporine, Tacrolimus, Prednisone | Ashwagandha stimulates immune system — directly counteracts these drugs |
| Hormone-sensitive cancer drugs | Prostate cancer medications | Ashwagandha may boost testosterone, accelerating disease |
Moderate (Use Only Under Medical Supervision)
| Drug Category | Examples | Risk |
|---|---|---|
| Blood sugar medications | Metformin, Glimepiride, Insulin | Additive blood sugar lowering → hypoglycemia |
| Blood pressure medications | Amlodipine, Telmisartan, Losartan | Additive BP lowering → dangerous hypotension |
| Thyroid medications | Levothyroxine (Thyronorm, Eltroxin) | T3/T4 elevation → thyrotoxicosis |
| Antidepressants | Sertraline, Escitalopram, Reboxetine | Reported: testicle pain, severe diarrhoea, myalgia, restless legs |
| Anticoagulants | Warfarin, Clopidogrel | May alter bleeding risk |
If you’re managing diabetes in India with medications like Metformin or Glimepiride, adding ashwagandha requires careful blood sugar monitoring to avoid dangerous hypoglycemic episodes.
Absolute Contraindications
- Pregnancy — rated “likely unsafe” by most authorities (see section below)
- Hormone-sensitive prostate cancer — testosterone-boosting effect may accelerate disease
- Pre-existing liver disease — 37.5% mortality rate in case series
- Active hyperthyroidism — ashwagandha further elevates T3/T4
- Scheduled surgery — affects blood sugar, blood pressure, and sedation response. Stop at least 2 weeks before any procedure.
- Autoimmune conditions — immune stimulation can flare lupus, rheumatoid arthritis, multiple sclerosis, Hashimoto’s
Ashwagandha During Pregnancy and Breastfeeding
During pregnancy: Contraindicated by most medical authorities. WebMD rates it “likely unsafe.”
However, the abortifacient claim has a contested origin. The claim traces back to a 2000 American Herbal Pharmacopoeia (AHP) report, which was cited in a 2009 WHO monograph. The AHP later stated their report was misrepresented. The Botanical Safety Handbook removed the abortifacient notice entirely in its 2nd edition (2022), reclassifying ashwagandha as Class 1 (safe when used appropriately).
Despite this: No clinical trial has tested ashwagandha safety during pregnancy. Until such data exists, no responsible recommendation can be made. Avoid it during pregnancy.
During breastfeeding: No human data exists on whether ashwagandha compounds pass into breastmilk. No studies on safety in nursing mothers or infants. Generally not recommended.
For evidence-based pregnancy nutrition guidance, see our pregnancy diet guide week by week — which covers what’s actually safe and proven during each trimester.
Indian Brand Comparison: What Your Money Actually Buys
This is the section every Indian consumer needs but no website provides honestly. We compared 6 major brands available across India.
Brand-by-Brand Breakdown
| Brand | Form | Dose Per Unit | Pack Size / MRP | Cost Per Unit | Extract Type | Withanolides (Est.) | Clinical Trials |
|---|---|---|---|---|---|---|---|
| Patanjali | Capsule | 500mg whole plant powder | 20 caps / ₹123 | ₹6.15 | Raw powder | 1–3mg | None |
| Himalaya | Tablet | 250mg root extract | 60 tabs / ₹229 | ₹3.82 | Concentrated extract | 4–8mg | None (own brand) |
| Organic India | Capsule | Undisclosed | 60 caps / ₹189 | ₹3.14 | Organic root | Undisclosed | None |
| Zandu Gold Plus | Capsule | Undisclosed | 60 caps / ₹468 | ₹7.80 | Enriched formula | Undisclosed | None |
| Kapiva Gold | Capsule | Undisclosed | 60 caps / ₹562 | ₹9.37 | High-potency extract | Undisclosed | Claimed |
| Nutrabox KSM-66 | Capsule | 600mg KSM-66 root extract | 60 caps / ₹1,399 | ₹23.32 | KSM-66 licensed | ~30mg (>5%) | 24+ (KSM-66) |
The Real Cost Analysis
The cheapest option is not what it seems:
Patanjali at ₹6.15/capsule delivers an estimated 1–3mg withanolides per capsule. To match KSM-66’s ~30mg of withanolides, you’d need 10–30 Patanjali capsules daily = ₹61–185/day = ₹1,830–5,550/month.
Nutrabox KSM-66 at ₹23.32/capsule delivers ~30mg withanolides in a single capsule = ₹23/day = ₹700/month.
Himalaya at ₹3.82/tablet delivers an estimated 4–8mg withanolides. To match KSM-66, you’d need 4–8 tablets daily = ₹15–31/day = ₹460–920/month.
Per withanolide delivered, the “expensive” brand is often the cheapest.
What Indian Brands Don’t Tell You
- Neither Himalaya nor Patanjali discloses withanolide percentage on packaging — this is the single most important quality metric, and the two largest brands hide it
- No Indian brand has published its own randomized controlled trial on PubMed — they rely on general ashwagandha research, not product-specific evidence
- “500mg” vs “250mg” is meaningless without knowing the extraction ratio and standardization — higher milligrams of raw powder often means fewer active compounds than a lower-milligram concentrate
- “GMP certified” is a manufacturing standard, not a potency guarantee — GMP means the factory is clean, not that the product contains what it claims
Raw Ashwagandha: Mandi Prices
For those sourcing directly: raw ashwagandha root trades at ₹15,000–19,800 per quintal in Indian mandis (average ₹17,000 as of May 2026). Retail whole root: ~₹170/kg.
The FSSAI 2026 Leaf Ban: What Changed and Why
On April 15, 2026, the Ministry of Ayush strictly prohibited ashwagandha leaves in all Ayush drugs and products.
On April 16, 2026, FSSAI extended this ban to the food and nutraceutical sector. Only roots and root extracts are now permitted under Schedule IV.
Why the Ban Happened
Testing of 584 commercial ashwagandha samples revealed:
- 119 samples (20.4%) were not pure root material
- 84 samples (14%) specifically contained leaf contamination
- 70-fold variation in daily withaferin-A intake across different commercial products
Leaves contain significantly higher concentrations of withaferin-A — the compound linked to:
- Liver toxicity (the 35 case reports)
- Gastrointestinal distress
- Potential neurotoxic effects
How Adulteration Happens
Leaves are cheaper to produce than roots. Unscrupulous manufacturers substitute leaf material (or whole plant) but label the product as “root extract.” Standard withanolide tests cannot distinguish root from leaf — both plant parts contain withanolides. Only advanced testing methods (HPLC, HPTLC, LC-MS, DNA barcoding) can identify which plant part was actually used.
The American Botanical Council has released a Laboratory Guidance Document specifically for detecting ashwagandha root adulteration — a sign of how widespread the problem is globally.
What This Means for Consumers
- Check your current supplement — does the label specify “root extract” or just “ashwagandha”? Vague labelling is a red flag.
- Branded standardized extracts (KSM-66, Sensoril, Shoden) have supply chain controls and are lower risk for adulteration
- Generic “ashwagandha” powders, especially cheap ones from unverified sources, have the highest adulteration risk
- Products containing Sensoril or Shoden may need reformulation — both extracts traditionally used root + leaf material. Post-ban, their Indian formulations may change.
Manufacturers must now disclose which plant part is used on labels. Non-compliance attracts action under the Food Safety and Standards Act, 2006.
Who Should NOT Take Ashwagandha
Based on clinical evidence, case reports, and pharmacological mechanisms, the following groups should avoid ashwagandha entirely:
Definite Avoid
- Pregnant women — insufficient safety data, historical (though contested) abortifacient classification
- Breastfeeding women — no data on breastmilk excretion
- People with liver disease — fatty liver, hepatitis, cirrhosis. 37.5% mortality in liver injury case series with pre-existing liver conditions
- People with hyperthyroidism or Graves’ disease — ashwagandha elevates T3/T4 further
- People with autoimmune conditions — lupus, rheumatoid arthritis, MS, Hashimoto’s thyroiditis. Immune stimulation can trigger flares
- People on benzodiazepines — synergistic sedation risk
- People on immunosuppressants — directly counteracted by ashwagandha’s immune-boosting effect
- Hormone-sensitive prostate cancer patients — testosterone-boosting effect may accelerate disease
- Anyone within 2 weeks of surgery — affects blood sugar, BP, and sedation
Use with Extreme Caution (Only Under Medical Supervision)
- Thyroid medication users — requires T3/T4/TSH monitoring every 4 weeks
- Diabetes medication users — hypoglycemia risk with blood sugar-lowering drugs
- Blood pressure medication users — hypotension risk
- Antidepressant users — serotonergic interactions, reported side effects include testicular pain and severe diarrhoea
- Anyone with a history of depression or emotional blunting — may worsen anhedonia symptoms
Monitor Closely
- First-time users — start with 250mg/day for 2 weeks before escalating to 600mg
- Users beyond 12 weeks — only one observational study exists for long-term use. Get a liver function test (LFT) at 3 months.
- Users experiencing diminishing effects — consider a 2–4 week break rather than increasing dose
For understanding what your CBC blood test results mean alongside supplementation, our complete guide explains every parameter and normal range for Indian adults.
How to Choose the Right Ashwagandha Product in India
Step 1: Know What Extract You Want
| If Your Goal Is | Choose | Why |
|---|---|---|
| Stress and cortisol reduction | KSM-66 or Shoden | Most clinical trial support |
| Muscle and testosterone | KSM-66 | Specific fitness trials |
| Sleep | KSM-66 (>600mg/day) | Indirect sleep benefit via cortisol. Note: direct sleep compound TEG is in leaves, now banned |
| Calming/anxiety | Sensoril | Higher withanolide concentration, traditionally calming |
| Budget option | Himalaya | Best quality-to-price ratio among mainstream brands |
| Maximum potency | Shoden | 35% withanolides — highest concentration |
Step 2: Check the Label
Look for these on the packaging:
- “Root extract” (not “whole plant,” “plant powder,” or just “ashwagandha”)
- Withanolide percentage (if listed — most Indian brands don’t disclose this)
- Standardised extract name (KSM-66, Sensoril, Shoden)
- FSSAI license number
- Batch number and expiry date
- “Does not contain leaves” (post-2026 ban, this should be standard)
Step 3: Avoid Red Flags
- No mention of which plant part is used
- Unusually cheap price (below ₹100 for 60 capsules)
- Claims of “100% pure” without third-party certification
- Unrealistic health claims on packaging
- No FSSAI number
- Selling in loose powder form without batch traceability
How to Take Ashwagandha: Practical Protocol
Starting Protocol (Week 1–2)
- Dose: 250mg/day of standardised extract (KSM-66 or equivalent)
- Timing: With breakfast or lunch (not before bed initially — some people get energised)
- With food: Always take with a meal to reduce GI side effects
- Monitor: Track sleep quality, mood, energy, and any digestive changes
Escalation Protocol (Week 3 Onwards)
- Increase to 300mg twice daily (600mg total) if tolerating well
- Timing: Split dose — morning and early afternoon
- For sleep: If using for sleep, take the second dose with dinner instead
- Continue for 8–12 weeks before evaluating results
Discontinuation Protocol
- Week 1 of taper: Reduce to 450mg/day (drop one dose to half)
- Week 2: Reduce to 300mg/day (single dose)
- Week 3: Reduce to 150mg/day
- Week 4: Stop completely
- Monitor for withdrawal symptoms — rebound anxiety, insomnia, brain fog
- If symptoms are severe, slow the taper to 6–8 weeks
Blood Work Timeline
- Before starting: Baseline liver function test (LFT), thyroid panel (T3, T4, TSH), fasting blood glucose
- Week 4: Repeat thyroid panel (especially if on thyroid medication)
- Week 12: Full panel — LFT, thyroid, testosterone (if relevant), cortisol
- Every 3 months if continuing beyond 12 weeks
Ashwagandha vs Other Adaptogens
How does ashwagandha compare to other popular adaptogens available in India?
| Parameter | Ashwagandha | Brahmi (Bacopa) | Shatavari | Rhodiola Rosea |
|---|---|---|---|---|
| Primary benefit | Cortisol reduction, strength | Memory, cognition | Women’s health, digestion | Fatigue, endurance |
| Onset time | 2–4 weeks | 8–12 weeks | 4–6 weeks | 1–2 weeks |
| Clinical trials | 24+ (KSM-66 alone) | 6+ RCTs | Limited | 10+ RCTs |
| Liver risk | Yes (35 case reports) | No significant reports | No significant reports | No significant reports |
| Withdrawal risk | Yes (documented) | Minimal | Minimal | Minimal |
| Drug interactions | 471 | Moderate | Low | Moderate |
| Best for | Stressed, active men | Students, elderly | Women (PCOS, menopause) | Athletes, shift workers |
| Available in India | Everywhere | Everywhere | Everywhere | Limited (mostly imported) |
The Long-Term Safety Question
What We Know (12-Month Data)
The only long-term study (n=191, prospective, observational, KSM-66):
- Mild adverse events in 9.4% of participants
- No clinically significant liver enzyme changes
- Cortisol decreased significantly (P < .001)
- Testosterone (free and total) increased significantly (P < .05)
- Lipid profile and fasting glucose unaffected
- Quality of life scores improved significantly
What We Don’t Know
- No placebo-controlled trial beyond 12 weeks
- No data on 2+ years of continuous use
- No study has tracked emotional blunting over time
- No data on ashwagandha’s effects on adolescents (most trials enrol adults 25–65)
- No data on interactions with long-term medications (most trials exclude people on other drugs)
- The 12-month study was observational — participants self-selected, no randomisation, no blinding. This is a weaker evidence standard than the 8-week RCTs.
The Contradiction
The 12-month study says “no liver enzyme changes.” The 35 case reports say “liver injury, 3 deaths.” These aren’t contradictory if you consider that:
- Case reports capture outliers — the 0.01% who react severely
- Observational studies capture averages — the 99.99% who do fine
- Pre-existing liver disease is the key risk factor, and most trials exclude these patients
- Adulterated products (leaf-containing) may cause more damage than pure root extracts
The responsible conclusion: Ashwagandha root extract is likely safe for most healthy adults at standard doses for up to 12 months. But it is not safe for everyone, and “herbal” does not mean “harmless.”
Frequently Asked Questions
Does ashwagandha cause weight gain?
No. The clinical data shows the opposite — a weight management RCT found ashwagandha users lost 2.32 kg versus 1.13 kg in the placebo group over 8 weeks. However, some users report appetite normalisation after cortisol suppression — if chronic stress was suppressing your appetite, reducing cortisol may restore normal hunger signals. Combined with resistance training, ashwagandha may increase lean muscle mass while reducing body fat percentage, which can show as stable weight on a scale despite improved body composition.
Can I take ashwagandha on an empty stomach?
You can, but most clinical trials administered it with meals. Taking ashwagandha on an empty stomach increases the likelihood of nausea, hyperacidity, and GI discomfort — especially in the first 1–2 weeks. If you experience stomach issues, switch to taking it with food.
Is ashwagandha safe for children?
No clinical trial data exists for children under 18. Most studies enrol adults aged 25–65. The hormonal effects (cortisol reduction, testosterone increase) make unsupervised use in adolescents particularly risky. Do not give ashwagandha to children without paediatric consultation.
How long does ashwagandha take to work?
Based on clinical trial timelines: cortisol reduction begins within 2–4 weeks. Significant stress and anxiety improvement by 4–8 weeks. Testosterone and muscle effects require 8–12 weeks. Sleep improvements are best documented after 8+ weeks at doses above 600mg/day.
Can I take ashwagandha with coffee?
There are no documented interactions between ashwagandha and caffeine. However, caffeine raises cortisol — the exact hormone ashwagandha lowers. Taking both simultaneously may partially negate ashwagandha’s cortisol-lowering benefit. If using ashwagandha for stress, consider separating intake by 2–3 hours from your coffee.
Is ashwagandha better in powder or capsule form?
Capsules of standardised extracts (KSM-66, Sensoril, Shoden) deliver consistent, measured doses of active withanolides. Raw powder (churna) has variable potency (0.5–2% withanolides), unpalatable taste, and higher adulteration risk — testing found powder forms are significantly more likely to contain leaf material than whole roots or encapsulated extracts. Unless you’re sourcing verified whole roots and preparing traditional Ayurvedic formulations, capsules are more reliable.
What blood tests should I get before taking ashwagandha?
At minimum: liver function test (LFT including ALT, AST, bilirubin), thyroid panel (T3, T4, TSH), and fasting blood glucose. If you’re male and interested in testosterone effects, add total and free testosterone. Repeat the thyroid panel at 4 weeks and the full panel at 12 weeks. This baseline protects you and gives you objective data on whether ashwagandha is actually working for you — rather than relying on subjective feelings.
Does ashwagandha interact with alcohol?
Ashwagandha has GABAergic activity — it modulates the same neurotransmitter system that alcohol affects. Combining the two can potentiate sedation. More concerning is the liver angle: alcohol depletes glutathione (the liver’s primary detox molecule), and ashwagandha has 35 documented cases of liver injury. The combination increases hepatotoxic risk. If you drink regularly, get your LFT checked before starting and retest at 4 weeks.
Where can I buy genuine ashwagandha in India?
Purchase from authorised retailers — official brand websites, 1mg, PharmEasy, Apollo Pharmacy, or verified Amazon/Flipkart sellers. Check for the FSSAI license number on packaging. For KSM-66 specifically, verify the brand is a licensed partner on the KSM-66 official website. Avoid loose powder from unverified sources, local “Ayurvedic” shops without brand packaging, or social media sellers.
This article is for informational purposes only and does not constitute medical advice. Ashwagandha is classified as a dietary supplement, not a medicine, and is not regulated with the same rigour as pharmaceutical drugs in India. Always consult a qualified healthcare provider before starting any supplement — especially if you are pregnant, breastfeeding, have liver or thyroid conditions, or are taking any medications. The data presented here is sourced from published clinical trials, peer-reviewed case reports, and regulatory notifications as of May 2026.
Sources & References
- PMC/NIH — An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract: A randomized, double-blind, placebo-controlled study (Lopresti 2019)
- PMC/NIH — Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract (Choudhary 2017)
- PMC/NIH — Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial (Wankhede 2015)
- PMC/NIH — Ashwagandha-associated liver injury: A case series from India and literature review (2024)
- PMC/NIH — Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults (Choudhary 2021)
- PMC/NIH — Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis (2023)
- PMC/NIH — Ashwagandha root extract on thyroid function in subclinical hypothyroid patients (Sharma 2018)
- FSSAI — Notification on prohibition of Ashwagandha leaves in food products (April 16, 2026)
- Ministry of Ayush — Order prohibiting use of Ashwagandha leaves in Ayush drugs and products (April 15, 2026)
- American Botanical Council — Laboratory Guidance Document for Ashwagandha Root Adulteration Detection
- PMC/NIH — Ashwagandha withdrawal presenting as acute anxiety: A case report (2025)
- Cureus — Parasomnia and transient amnesia associated with ashwagandha ingestion: case report
Frequently Asked Questions
Is Patanjali Ashwagandha better than Himalaya Ashwagandha?
No. Patanjali uses whole plant powder (500mg per capsule) with an estimated 1–3mg of active withanolides. Himalaya uses a concentrated root extract (250mg per tablet) delivering an estimated 4–8mg of withanolides. Despite Patanjali's higher milligram number, Himalaya likely delivers 2–4x more active compound per dose. Neither brand discloses withanolide percentages on packaging — a major transparency gap in India. For clinically studied potency, KSM-66 branded extracts (used by Nutrabox, Carbamide Forte) guarantee >5% withanolides (~30mg per 600mg capsule) and have 24+ published clinical trials.
Can ashwagandha damage the liver?
Yes. Since 2017, 35 case reports of ashwagandha-associated liver injury have been published globally. An Indian case series of 8 patients showed liver injury onset as early as 14 days after starting the supplement. Three of those 8 patients died — all 3 had pre-existing chronic liver disease. Survivors recovered in 1–4 months after discontinuation. The suspected culprit is withaferin-A, found in higher concentrations in leaves (now banned by FSSAI). If you have any liver condition — fatty liver, hepatitis, cirrhosis — do not take ashwagandha without medical supervision.
What is the correct ashwagandha dosage based on clinical trials?
Clinical trials that showed real results used these specific doses: KSM-66 at 600mg/day (300mg twice daily) for stress, weight loss, muscle strength, and testosterone. Shoden at 240mg/day (35% withanolides = 84mg active compound) for cortisol reduction. For sleep, doses above 600mg/day for more than 8 weeks showed the best results. A dose-response study confirmed 600mg/day was significantly more effective than 250mg/day. Generic ashwagandha churna at typical 500mg–1g doses delivers dramatically less active withanolides than these standardized extracts.
Does ashwagandha really increase testosterone?
Yes, but the effect is moderate and population-specific. In men doing resistance training, KSM-66 at 600mg/day increased testosterone by 96 ng/dL versus 18 ng/dL in the placebo group over 8 weeks. In stressed overweight men, the increase was 14.7%. In infertile men, 5g root powder daily for 3 months improved sperm count, motility (+87%), and testosterone. However, these effects are estimated at only 25–40% of creatine's effect on muscle and 40–60% on strength. Ashwagandha is not a replacement for testosterone replacement therapy when levels are clinically low. Effects are most pronounced in men who are stressed, overweight, or have fertility issues.
Can I take ashwagandha with thyroid medication?
This is a potentially dangerous combination. An 8-week clinical study showed ashwagandha increased T3 by 41.5% and T4 by 19.6% in hypothyroid patients. If you're already taking levothyroxine (Thyronorm, Eltroxin), adding ashwagandha can push your thyroid levels too high — risking thyrotoxicosis. A 73-year-old woman developed supraventricular tachycardia after 2 years of combining both. Worse, for Hashimoto's thyroiditis (autoimmune hypothyroidism), ashwagandha stimulates the immune system and can paradoxically flare the autoimmune attack on your thyroid. Never combine without endocrinologist supervision and regular thyroid panel monitoring.
What are ashwagandha withdrawal symptoms?
Ashwagandha withdrawal is real and clinically documented. A published case report describes a 20-year-old male taking 600mg/day who abruptly stopped and developed tachycardia (89 bpm), insomnia, anxiety, hypertension, and loss of appetite — presenting to the emergency department on day 7. The mechanism involves GABAergic pathway dependence, similar to benzodiazepine withdrawal. Commonly reported symptoms include brain fog, headaches, rebound anxiety, panic attacks, and drops in motivation. Symptoms typically appear within 1–3 days and resolve in a few days to 2 weeks. The recommended approach is to taper by 25% per week over 2–4 weeks rather than stopping abruptly.
Why did FSSAI ban ashwagandha leaves in 2026?
On April 16, 2026, FSSAI prohibited ashwagandha leaves in all food and nutraceutical products across India. The Ministry of Ayush issued a similar ban the day before for Ayush drugs. Only roots and root extracts are now permitted under Schedule IV. The ban was driven by safety data showing leaves contain significantly higher concentrations of withaferin-A — the compound linked to liver toxicity, gastrointestinal distress, and potential neurotoxic effects. Testing of 584 commercial samples revealed 20.4% contained non-root material, with 14% specifically containing leaf contamination. India being the world's largest ashwagandha producer means this ban affects global supplement supply chains.
Does ashwagandha cause emotional blunting or anhedonia?
Clinical trials have not documented this side effect, but hundreds of users on Reddit and health forums report emotional blunting, anhedonia (inability to feel pleasure), and emotional numbness after weeks to months of use. Some users describe it as crossing from relaxed to detached. One user reported anhedonia persisting 2.5 years after stopping. The proposed mechanism involves chronic GABAergic modulation reducing 5-HT1A receptor sensitivity and increasing 5-HT2 receptor sensitivity — a pathway similar to Post-SSRI Sexual Dysfunction. This is a significant blind spot in clinical research, which typically runs only 8–12 weeks and uses structured questionnaires that don't capture anhedonia.
What is the difference between KSM-66, Sensoril, and Shoden ashwagandha?
These are three distinct patented extracts with different compositions. KSM-66 uses only roots, extracted via a proprietary milk-based process, standardized to >5% withanolides, backed by 24+ clinical trials and 14 years of R&D. Sensoril uses roots and leaves, water-based extraction, standardized to >10% withanolides, with 12+ studies. Shoden uses roots and leaves, standardized to >35% withanolides — the highest concentration — but has only 3 human trials. Generic ashwagandha powder contains just 0.5–2% withanolides. Note: since the FSSAI 2026 leaf ban, Sensoril and Shoden products sold in India may need reformulation if they contain leaf-derived material.
How many drug interactions does ashwagandha have?
Ashwagandha has 471 known drug interactions — 7 major, 279 moderate, and 185 minor. The most dangerous combinations are with sedatives and benzodiazepines (Alprazolam, Diazepam, Lorazepam), which risk synergistic sedation and respiratory depression. Blood sugar medications (Metformin, Glimepiride) combined with ashwagandha's glucose-lowering effect can cause hypoglycemia. Blood pressure medications can cause dangerous hypotension. Immunosuppressants (Cyclosporine, Tacrolimus) are directly counteracted by ashwagandha's immune-boosting properties. Thyroid medications risk thyrotoxicosis. Hormone-sensitive prostate cancer drugs should never be combined, as ashwagandha may boost testosterone and accelerate the disease.
Disclaimer: This content is for informational and educational purposes only, based on published research and publicly available data. It does not constitute medical advice, diagnosis, or treatment recommendations. Drug prices are approximate and vary by dosage, formulation, brand, and pharmacy. Always consult a qualified healthcare professional before making any decisions about medication. Fittour India is not a pharmacy, drug seller, or licensed medical provider.